Understanding Genomics and Genetic Testing in Cancer Immunotherapy

Показать описание

A former CRI fellow from 2012-2015, Dr. Corrie Painter is currently the associate director of operations and scientific outreach in the Cancer Program of the Broad Institute of MIT and Harvard. Dr. Corrie Painter also serves as the associate director of Count Me In, which launches patient-driven research projects across multiple cancer types.

Dr. Eliezer Van Allen is an assistant professor of medicine at Harvard Medical School, a clinician at Dana-Farber/Partners Cancer Care, and an associate member at the Broad Institute of MIT and Harvard. His research focuses on computational cancer genomics, the application of new molecular profiling technologies to advance precision cancer medicine, and studying resistance to cancer therapeutics.

The “Cancer Immunotherapy and You” webinar series is produced by the Cancer Research Institute and is hosted by our science writer, Arthur Brodsky, Ph.D. The 2020 series is made possible with generous support from Bristol-Myers Squibb, Alkermes, and Foundation Medicine.

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.